Giacomo Lus

7PUBLICATIONS
77CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyAutoimmunityProsthetics and orthoticsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 11, 2026
FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.

|Nov 24, 2025
Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.

Ermelinda De Meo, Ilaria Addazio, Emilio Portaccio

|May 28, 2025
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis.

|Apr 25, 2024
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis.

Gianmarco Abbadessa, Maria Teresa Lepore, Sara Bruzzaniti

|Dec 21, 2022
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis.

Giacomo Boffa, Alessio Signori, Luca Massacesi

|Jan 20, 2022
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.

Pietro Iaffaldano, Giuseppe Lucisano, Alessia Manni

Pageof 2

Frequent Collaborators

3 joint publications

Gianmarco Abbadessa

3 joint publications

Simona Bonavita

3 joint publications

Massimo Filippi

3 joint publications

Alessandra Lugaresi